These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8666354)

  • 1. Subcutaneous octreotide for the prevention of early variceal rebleeding.
    DeLédinghen V; Ripault MP; Silvain C; Beauchant M; Raffoux N; Bouquet S
    Hepatology; 1996 Apr; 23(4):938-40. PubMed ID: 8666354
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised trial of octreotide for long term management of cirrhosis after variceal hemorrhage.
    Sheikh RA; Trudeau WL
    Gastrointest Endosc; 1998 Sep; 48(3):328-30. PubMed ID: 9744619
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological prevention of rebleeding.
    Nader A; Grace ND
    Gastrointest Endosc Clin N Am; 1999 Apr; 9(2):301-10. PubMed ID: 10333444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of variceal rebleeding: endoscopes, drugs, and more.
    Bosch J
    Hepatology; 2000 Sep; 32(3):660-2. PubMed ID: 10960465
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs, ligation or both for the prevention of variceal rebleeding?
    Schepke M
    Gut; 2009 Aug; 58(8):1045-6. PubMed ID: 19592688
    [No Abstract]   [Full Text] [Related]  

  • 6. [Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Oct; 82(10):947-50. PubMed ID: 15686191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.
    Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B
    Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis.
    Zuberi BF; Baloch Q
    Am J Gastroenterol; 2000 Mar; 95(3):768-71. PubMed ID: 10710072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
    Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
    Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal hypertension and variceal hemorrhage.
    Sass DA; Chopra KB
    Med Clin North Am; 2009 Jul; 93(4):837-53, vii-viii. PubMed ID: 19577117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial.
    Morales GF; Pereira Lima JC; Hornos AP; Marques DL; Costa CS; Lima Pereira L; Lopes CV; Raymondi R; Marroni CA
    Hepatogastroenterology; 2007; 54(73):195-200. PubMed ID: 17419259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of endoscopic variceal ligation for the prophylaxis of rebleeding from oesophageal varices. Prospective study about 102 cases].
    Bouzaïdi S; Ben Hammouda I; Ben Yedder J; Ben Salem M; Jemaa Y; Trabelsi S; Moussa A; Debbech R; Salem M; Najjar T
    Tunis Med; 2004 Jun; 82(6):531-7. PubMed ID: 15517952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage.
    Shah HA; Mumtaz K; Jafri W; Abid S; Hamid S; Ahmad A; Abbas Z
    J Ayub Med Coll Abbottabad; 2005; 17(1):10-4. PubMed ID: 15929518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
    Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
    Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of octreotide in the control of acute upper gastrointestinal bleeding.
    Kullavanuaya P; Manotaya S; Thong-Ngam D; Mahachai V; Kladchareon N
    J Med Assoc Thai; 2001 Dec; 84(12):1714-20. PubMed ID: 11999818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of variceal rebleeding--approach to management.
    Mela M; Thalheimer U; Burroughs A
    MedGenMed; 2003 Jun; 5(2):9. PubMed ID: 14603108
    [No Abstract]   [Full Text] [Related]  

  • 17. Octreotide and bleeding oesophageal varices.
    O'Donnell LJ; Farthing MJ
    Lancet; 1989 Nov; 2(8674):1276. PubMed ID: 2573785
    [No Abstract]   [Full Text] [Related]  

  • 18. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
    de la Peña J; Brullet E; Sanchez-Hernández E; Rivero M; Vergara M; Martin-Lorente JL; Garcia Suárez C
    Hepatology; 2005 Mar; 41(3):572-8. PubMed ID: 15726659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second study shows that octreotide may prevent early rebleeding in cirrhosis.
    D'Amico G; Politi F; D'Antoni A; Giannuoli G; Pasta L; Vizziani G; Traina M; Morabito A; Pagliaro L
    BMJ; 1998 Apr; 316(7140):1320. PubMed ID: 9554914
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of hemorrhage from esophageal varices].
    Sauerbruch T; Paumgartner G
    Internist (Berl); 1987 Jul; 28(7):459-67. PubMed ID: 3305409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.